MedTrace Logo

Efficacy of Anaferon for Children in the Treatment of Influenza and Acute Respiratory Viral Infections in Children

NCT02072174 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 569

Last updated 2019-07-12

Study results available
· View outcomes & findings →

Summary

The purpose of this study is:

• To obtain additional data on therapeutic efficacy of Anaferon for children in the treatment of influenza and acute respiratory viral infections in children

Conditions

  • Influenza and Acute Respiratory Viral Infections

Interventions

DRUG

Anaferon for Children

Anaferon for children: For oral use.

Sponsors & Collaborators

  • Materia Medica Holding

    lead INDUSTRY

Principal Investigators

  • Elena Andrianova, Professor · Materia Medica Holding

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
3 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-08
Primary Completion
2018-04-16
Completion
2018-04-16

Countries

  • Belarus
  • Russia
  • Ukraine

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02072174 on ClinicalTrials.gov